Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal dexamethasone + bupivacaine versus bupivacaine alone for spinal analgesia in elective cesarean section
IRCT20221126056613N2Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Mar 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in postoperative pain comparing Control: bupivacaine alone with Intervention: dexamethasone + bupivacaine (2 arms). Primary endpoints: Duration of analgesia, Sensory block after cesarean and 6 more. Started Mar 2023; status: completed.
02
Drugs
dexamethasonebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20221126056613N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221126056613N2.